Pharmacognosy Chapter 3 Notes – Quality Control of Crude Drugs (ER20)
By Arvind Sharma, B.Pharm, M.Pharm, Assistant Professor, MUIT
Smart Pharmacy Notes
Pharmacognosy Chapter 3 Notes – Quality Control of Crude Drugs (ER20)
Introduction to Quality Control of Crude Drugs
Quality control of crude drugs is a fundamental aspect of Pharmacognosy, ensuring the safety, efficacy, and purity of natural medicinal products. It involves a series of systematic tests and analyses to verify the identity, purity, and strength of crude drugs before they are used in medicinal preparations. This chapter aligns with the D.Pharm 1st Year PCI ER20 syllabus, providing students with essential knowledge to prepare for their examinations and future professional practice in pharmacy. Understanding these principles is crucial for preventing adulteration and ensuring consistent therapeutic outcomes.
Topics Covered
- Adulteration of Crude Drugs
- Methods of Adulteration
- Evaluation of Crude Drugs
- Organoleptic Evaluation
- Microscopic Evaluation
- Physical Evaluation
- Chemical Evaluation
- Biological Evaluation
Quality Control of Crude Drugs: Core Concepts
Definition of Quality Control
Quality Control (QC) in Pharmacognosy refers to the set of procedures and methods employed to ensure that a crude drug meets the prescribed standards of quality, purity, and strength. It involves checking for identity, absence of foreign matter, freedom from pests, appropriate moisture content, and the presence of active constituents within specified limits. The primary goal is to establish the authenticity and consistency of crude drugs to guarantee their therapeutic efficacy and safety.
Adulteration of Crude Drugs
Adulteration is the most common and serious problem in the herbal drug industry. It refers to the debasement of any crude drug by intentionally mixing it with inferior, substandard, or foreign materials. This practice can occur during collection, cultivation, processing, or storage, primarily for economic gain or due to ignorance. Adulterated drugs not only pose health risks but also diminish the therapeutic value of medicinal products.
Methods of Adulteration
| Type of Adulteration | Description | Example |
|---|---|---|
| Substitution with Inferior/Spurious Drugs | Replacing genuine drugs with substandard, commercially cheaper, or entirely different materials that may or may not have therapeutic activity. | Direct Substitution: Digitalis purpurea leaves replaced by Verbascum thapsus leaves. Substitution with Exhausted Drugs: Using exhausted ginger (after extraction of oil) in place of fresh ginger. |
| Admixture/Sophistication | Deliberate addition of substandard or foreign materials to increase bulk or mask poor quality. This includes mixing foreign organic matter or other parts of the same plant with less active constituents. | Adding stones, sand, or stems of the same plant (e.g., senna stems with senna leaves). Mixing powdered belladonna leaves with stramonium leaves. |
| Deterioration | Impairment of the quality of a drug due to improper collection, processing, storage, or pest infestation, leading to loss of active constituents or accumulation of harmful substances. | Fungi or insect infestation in stored crude drugs like cereals or spices. Loss of volatile oils due to improper drying or storage. |
| Sophistication | Intentional addition of a product for increasing its weight or value, or to mask an inferior quality. (Often overlaps with Admixture). | Adding powdered bark of Pterocarpus marsupium to red sandalwood. Adding artificial coloring agents to turmeric powder. |
| Substitution with Synthetic/Artificial Products | Replacing natural drugs with synthetic compounds or artificial preparations that mimic the appearance or action of the natural product. | Using synthetic vanillin instead of natural vanilla pods. Artificial resins replacing natural gums. |
Evaluation of Crude Drugs
Evaluation of crude drugs is the process of confirming their identity, quality, and purity. It involves systematic examination using various methods to ensure that the drug meets pharmacopoeial standards and is suitable for medicinal use. The main evaluation methods are organoleptic, microscopic, physical, chemical, and biological.
Organoleptic Evaluation
Organoleptic evaluation involves assessing crude drugs using sensory organs. It provides a quick and preliminary assessment of the drug's identity and quality. These characteristics are often unique to a particular drug.
- Color: The characteristic color of the drug (e.g., brown for cinnamon bark, green for senna leaves).
- Odor: The distinctive smell (e.g., aromatic for cloves, pungent for ginger, camphoraceous for eucalyptus).
- Taste: The characteristic taste (e.g., bitter for quinine, sweet for liquorice, mucilaginous for ispaghula).
- Size and Shape: The typical dimensions and form of the drug (e.g., entire leaves, powdered root, fractured pieces).
- Texture: How the drug feels to the touch (e.g., smooth, rough, brittle, fibrous).
Microscopic Evaluation
Microscopic evaluation involves examining the cellular and structural features of crude drugs using a microscope. It is particularly useful for identifying powdered drugs and detecting adulterants that have distinct cellular characteristics.
- Cell Structure: Identifying specific cell types, tissues (e.g., parenchyma, sclerenchyma, xylem, phloem).
- Stomata: Type and distribution of stomata on leaves (e.g., anomocytic, anisocytic, paracytic).
- Trichomes: Presence and type of hairs (e.g., glandular, non-glandular, unicellular, multicellular).
- Crystal Structures: Presence and form of calcium oxalate crystals (e.g., rosette, prism, cluster).
- Starch Grains: Shape, size, and hilum characteristics of starch grains.
- Lignification: Presence and extent of lignified tissues.
- Pollen Grains: Characteristic shape and size of pollen grains in certain drugs.
Microscopic evaluation also includes quantitative microscopy, such as determining stomatal index, palisade ratio, vein-islet number, and lignified cell counts, which are specific to certain drugs and help in detecting adulteration.
Physical Evaluation
Physical evaluation involves determining various physical constants of crude drugs. These parameters are often characteristic of a particular drug and help in establishing its identity, purity, and quality.
| Parameter | Description & Significance |
|---|---|
| Moisture Content | Description: Amount of water present in the crude drug. Determined by heating the drug to a constant weight or by Karl Fischer titration. Significance: High moisture content promotes enzymatic activity, microbial growth, and hydrolysis of active constituents, leading to spoilage. Low moisture ensures stability and better storage. Max limit typically 5-10% (w/w). |
| Ash Value | Description: The residue remaining after ignition of the crude drug, indicating the total inorganic content. Includes total ash, acid-insoluble ash, and water-soluble ash. Significance: - Total Ash: Measures the total amount of inorganic matter, including both physiological ash (part of the plant) and non-physiological ash (adulterants like soil, sand). - Acid-Insoluble Ash: Represents silica (sand, soil) and indicates contamination or adulteration with siliceous matter. - Water-Soluble Ash: Represents inorganic matter soluble in water, useful for detecting adulteration with carbonates, oxalates. |
| Extractive Value | Description: The amount of soluble constituents extracted from the crude drug using specific solvents (e.g., water, alcohol, ether). Cold and hot maceration/percolation methods are used. Significance: Indicates the proportion of active or inert constituents soluble in a given solvent, reflecting the quality and potential therapeutic activity. Useful for drugs that cannot be assayed chemically. For example, water-soluble extractive for senna, alcohol-soluble for resins. |
| Volatile Oil Content | Description: The percentage of volatile (essential) oils present in drugs like cloves, fennel, peppermint. Determined by distillation in a Clevenger apparatus. Significance: Essential for drugs whose therapeutic activity is due to volatile oils. Helps ensure the drug meets pharmacopoeial standards for aroma and therapeutic efficacy. Low content indicates exhausted drug or poor storage. |
| Refractive Index | Description: A measure of how much the path of light is bent when passing from one medium to another. Applicable to transparent liquids or solutions (e.g., volatile oils, fatty oils, resins). Significance: Each pure substance has a characteristic refractive index. It helps determine the purity and identity of oils and other liquid extracts, detecting adulteration with other oils or solvents. |
| Optical Rotation | Description: The angle by which a plane-polarized light is rotated when passing through a solution of a chiral substance. Measured using a polarimeter. Significance: Many natural products (e.g., sugars, alkaloids, essential oils) are optically active. It helps determine the purity and identity of such compounds, distinguishing between enantiomers or detecting adulteration with optically inactive substances. |
| Viscosity | Description: A measure of a fluid's resistance to flow. Determined using viscometers (e.g., Ostwald, Ubbelohde). Significance: Important for liquid crude drugs, fixed oils, and mucilages. Alterations in viscosity can indicate changes in composition or presence of adulterants (e.g., thinning of oils with cheaper alternatives, or thickening due to degradation products). |
| Melting Point | Description: The temperature at which a solid substance changes to a liquid state. Significance: Characteristic for crystalline compounds (e.g., fats, waxes, certain phytoconstituents). A sharp melting point indicates purity, while a wide range or depressed melting point suggests impurities or adulteration. |
| Foreign Matter | Description: Any matter present in the crude drug that does not belong to the drug itself. This includes foreign organic matter (parts of other plants, insects, animal excreta) and foreign inorganic matter (soil, stones, sand). Significance: Determines the purity of the crude drug. Pharmacopoeial limits are set for the maximum percentage of foreign matter allowed, usually not more than 2% w/w. Exceeding limits indicates poor collection or processing. |
Chemical Evaluation
Chemical evaluation involves analyzing the chemical constituents of crude drugs to determine their identity, purity, and strength. This is often the most precise method of evaluation, especially for drugs with known active principles.
| Parameter | Description & Significance |
|---|---|
| Active Constituent Assays | Description: Quantitative determination of the specific chemical compounds responsible for the therapeutic activity of the drug (e.g., alkaloids, glycosides, volatile oils, resins). Significance: Directly measures the strength and efficacy of the drug. Ensures that the drug contains the minimum required amount of active constituents as per pharmacopoeial standards. Methods include gravimetric, volumetric, spectrophotometric, and chromatographic techniques. |
| Chromatographic Techniques | Description: Advanced analytical methods used for separation, identification, and quantification of complex mixtures of phytoconstituents. Examples include Thin Layer Chromatography (TLC), High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), and High-Performance Thin Layer Chromatography (HPTLC). Significance: Provides a "fingerprint" of the drug's chemical composition, allowing for identification, detection of adulterants, and quantification of active markers. Very sensitive and specific, crucial for ensuring chemical authenticity and purity, especially for complex herbal formulations. |
| pH Value | Description: A measure of the acidity or alkalinity of an aqueous solution of the crude drug. Significance: Changes in pH can indicate degradation (e.g., hydrolysis of esters), microbial contamination, or presence of acidic/alkaline adulterants. Each drug has a characteristic pH range for its aqueous extract, which helps in quality assessment. |
| Acid Value | Description: The number of milligrams of potassium hydroxide (KOH) required to neutralize the free fatty acids present in 1 gram of fat or oil. Significance: Indicates the extent of rancidity and degradation of fatty oils and resins. High acid value suggests hydrolysis of triglycerides, often due to improper storage, exposure to light/air, or microbial action, leading to decreased quality and potential toxicity. |
| Saponification Value | Description: The number of milligrams of KOH required to saponify 1 gram of fat or oil (i.e., to neutralize all free fatty acids and saponify all esters present). Significance: Indicates the average molecular weight of the fatty acids present in fats and oils. Useful for detecting adulteration of expensive oils with cheaper ones, as different oils have characteristic saponification values. Helps identify various fixed oils and waxes. |
| Iodine Value | Description: The number of grams of iodine absorbed by 100 grams of fat or oil. Significance: Indicates the degree of unsaturation (number of double bonds) in the fatty acids of oils and fats. Higher iodine value means more unsaturation. Useful for characterizing fixed oils (e.g., drying oils vs. non-drying oils) and detecting adulteration, such as adding saturated oils to unsaturated ones. |
| Ester Value | Description: The difference between the saponification value and the acid value. It represents the number of milligrams of KOH required to saponify the esters present in 1 gram of fat or oil. Significance: Provides information about the amount of esters present. Useful for characterizing waxes, volatile oils, and resins, and can help detect adulteration, especially when combined with other values like acid and saponification values. |
Biological Evaluation
Biological evaluation, or bioassays, assesses the pharmacological activity of crude drugs on living organisms (animals, isolated organs, microorganisms). This method is crucial when the active constituents are unknown, difficult to isolate, or when their chemical assay is impractical.
- Bioassays: Involve quantifying the drug's effect on a biological system and comparing it to a standard preparation. Examples include:
- **Digitalis:** Assayed on pigeons or frogs to determine its cardiac stimulant activity.
- **Insulin:** Assayed on rabbits to determine its hypoglycemic activity.
- **Vitamins:** Assayed on animals to check their growth-promoting or deficiency-preventing effects.
- **Antibiotics:** Assayed using microbial inhibition zones to determine their potency. - Pharmacological Activity Tests: Direct measurement of the specific pharmacological effect of the drug (e.g., antispasmodic activity, anti-inflammatory effect, analgesic effect).
- Toxicity Studies: Assessing the acute and chronic toxicity of crude drugs or their extracts to ensure safety.
Author: Arvind Sharma, Assistant Professor, MUIT.
Important Points for Exams
- Adulteration: Understand the different types and be able to provide examples for each (e.g., exhausted drugs, foreign matter).
- Five Evaluation Methods: Memorize all five methods (Organoleptic, Microscopic, Physical, Chemical, Biological) and their key characteristics.
- Organoleptic Parameters: Recall specific senses used (color, odor, taste, size, shape, texture).
- Microscopic Features: Be able to list important microscopic elements like stomata, trichomes, calcium oxalate crystals, and starch grains.
- Physical Constants: Know the significance of moisture content, ash values (total, acid-insoluble, water-soluble), and extractive values. Remember volatile oil content.
- Chemical Parameters: Understand the purpose of active constituent assays, chromatographic techniques, and values like acid value, saponification value, and iodine value.
- Biological Evaluation: Recognize when bioassays are necessary and cite examples like digitalis assay on pigeons or antibiotics on microbes.
- Pharmacopoeial Standards: Always relate evaluation methods to ensuring compliance with official pharmacopoeial standards.
Download Notes PDF
Click below to download Chapter 3 Notes PDF:
Other Chapters
- Chapter 1 – Introduction to Pharmacognosy
- Chapter 2 – Classification of Crude Drugs
- Chapter 3 – Quality Control of Crude Drugs
- Chapter 4 – Phytoconstituents
- Chapter 5 – Medicinal Crude Drugs
- Chapter 6 – Surgical Dressings
- Chapter 7 – Traditional Systems
- Chapter 8 – Medicinal Plants Economy
- Chapter 9 – Herbs as Health Foods
- Chapter 10 – Herbal Formulations
- Chapter 11 – Herbal Cosmetics
- Chapter 12 – Phytochemical Investigation
Keywords
Pharmacognosy Chapter 3 Notes, Quality Control of Crude Drugs Notes, D Pharm Pharmacognosy ER20 Notes